Figure 5. Cumulative graft survival curves and OGTT.
(A): Graft survival in diabetic Balb/c mice transplanted with encapsulated human islets (n=29) vs. non-encapsulated human islets (n=5); *p <0.0001; (B): Average glycemic levels during OGTT in diabetic Balb/c mice transplanted with encapsulated human islets (transplanted group, n=5), non-transplanted diabetic Balb/c mice (diabetic control, n=5), and non-transplanted, non-diabetic Balb/c mice (normal control, n=5) five weeks post transplantation.